about
Long QT Syndrome: An Emerging Role for Inflammation and ImmunityPeculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosisHepato-cardiac disordersCirrhotic Cardiomyopathy: A New Clinical Phenotype.Arrhythmia risk in liver cirrhosis.Diaphragmatic herniation due to massive hepatomegaly in a patient with pulmonary arterial hypertensionCardiac and hepatic role of r-AtHSP70: basal effects and protection against ischemic and sepsis conditions.Establishment and validation of ALPH-Q score to predict mortality risk in patients with acute-on-chronic hepatitis B liver failure: a prospective cohort studyAssociation of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary interventionLiver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery.Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.Review article: the endocannabinoid system in liver disease, a potential therapeutic target.Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.Cardiohepatic syndrome.Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspectsPortopulmonary hypertension: an update.Arrhythmogenic potential develops rapidly at graft reperfusion before the start of hypotension during living-donor liver transplantation.Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.Hepatorenal syndrome with cirrhotic cardiomyopathy: case report and literature review.Complications of cirrhosis. A 50 years flashback.Cirrhotic Multiorgan Syndrome.Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESCFIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients.Cardiac manifestations in alcoholic liver disease.Hepatic sinusoids in liver injury, inflammation, and fibrosis: new pathophysiological insights.Clinical Phenotypes of Fontan Failure: Implications for Management.Diastolic dysfunction in cirrhosis.Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor.Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: a microneurographic study.Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosisCardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.The impact of cardiac resynchronization therapy on routine laboratory parameters.Reasons for, and outcomes of patients who were referred for a ventricular assist device but were declined: the recent era forgotten ones.Slow ventricular tachycardia presenting with acute liver failure.Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure.Anesthetic management during the first combined heart-liver transplant performed in Korea: a case report.TOTAL-BODY PET: MAXIMIZING SENSITIVITY TO CREATE NEW OPPORTUNITIES FOR CLINICAL RESEARCH AND PATIENT CARE.Liver Transplantation in Patients With Cardiac Disease.The impact of non-alcoholic fatty liver disease fibrosis score on cardiac prognosis in patients with chronic heart failure.
P2860
Q26769710-C4A9E50F-3A78-49A2-B9CD-D3862F46617AQ26992215-7E64D565-B228-4818-8FB8-FA2327B49A19Q26997114-73B83EFB-299A-4EC2-BCA8-31703B2FA56AQ33848796-8915DA2D-E1AC-4375-BB78-BED09667784AQ35308671-2AB2E0DB-890C-4E98-9D65-3E63A8952841Q35779180-D9677F4B-ABBC-4BF9-91DF-4FA245E6DBE9Q35879483-211E7B0D-8B47-45D5-86DC-35354646F54AQ36151463-42D0C429-9AB7-4BEE-9175-CB52E87540AEQ36262814-57020806-51C1-43E4-B3A9-D215A32F37B5Q36679145-430DD2B0-B4ED-4A68-A81B-F578BC26AB1DQ37642747-BD3BCDDD-5828-43BC-8D83-359AFB14BF8CQ38194626-6CF2CCD6-5ABE-4232-9BBB-9731C77DD3F7Q38199770-8C5B6F12-DEED-423D-87E5-F7C3C0277348Q38267664-2B7CC40F-CD31-425A-9BBB-9BF5286BC9AEQ38268612-EB0D97AA-CED5-42D2-9BDD-937703E41C87Q38293632-C1470CAE-5959-421E-AA34-0B277F991EBCQ38382110-2D907AED-8E44-40E3-AB08-2C2728145874Q38383495-ABAC73FB-B689-41E8-91C2-C7A564DB5FF1Q38421243-7E8F7B80-CE91-43A7-A0E4-7FEF2EF6324EQ38424360-BBA91952-BD20-4652-98B0-EBEA5D1A7ADDQ38538183-5FBCBBD5-82D5-424E-AE4C-7918144BFEACQ38676886-09B0C0A1-BC18-4F38-A9CD-6A3CEFFC9CA1Q38679137-05C567E5-DADB-49E2-A6AD-EC7FCDDF5516Q38724506-F6C9D473-7461-40EC-BD27-358CB1C6A314Q38759447-18435FAA-D4C6-408A-9D15-4F2A47B0753AQ38844501-364F52C3-C591-41E5-B121-671E5C33ECA3Q38881630-0C32CCDC-CC54-49BE-A421-4613CB43B8D5Q39247505-C4087405-855F-4DF0-B9E8-D338E20A0898Q40029009-842E1DB0-3DF7-4255-BFE1-C33D2399C05BQ40160690-0810DB81-6325-4159-92BF-495DFA84F2A4Q40719773-17E0B6E1-7E3C-4E8B-A004-F75653FD1CFAQ40871375-FD22F12D-D22E-40E6-8E28-FACCCAC0233FQ41105358-48E6EC8E-9907-4A9C-9965-65DEB8A1699BQ41109533-925B1969-F001-493F-8C17-2933EC3C64B5Q41137155-03141884-9A3B-44C7-BA0D-2E6BE9BC42E8Q42201388-881B9B23-C5FB-4DB2-8BA7-50BCCAF5D4F8Q42379742-FF8214D6-52CB-4606-8FA0-5A08EC3C30E2Q46035229-842DD8A1-5684-489F-981F-1939AE3549E5Q46706110-663A23E0-5B14-4A55-AEE0-6697F24A61C3Q47890127-D17B088E-6FE0-4804-A4A3-2A7E4AFA1C63
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interactions of the heart and the liver.
@en
type
label
Interactions of the heart and the liver.
@en
prefLabel
Interactions of the heart and the liver.
@en
P2860
P356
P1476
Interactions of the heart and the liver
@en
P2093
Mauro Bernardi
P2860
P304
P356
10.1093/EURHEARTJ/EHT246
P50
P577
2013-07-12T00:00:00Z